ASLAN Pharmaceuticals Ltd ADR (NASDAQ: ASLN) is 31.20% higher on its value in year-to-date trading and has touched a low of $0.39 and a high of $4.69 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ASLN stock was last observed hovering at around $1.63 in the last trading session, with the day’s loss setting it -0.94%.
Currently trading at $0.69, the stock is 9.16% and 12.58% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 12.87 million and changing -57.98% at the moment leaves the stock -59.01% off its SMA200. ASLN registered -75.97% loss for a year compared to 6-month loss of -67.38%. The firm has a 50-day simple moving average (SMA 50) of $0.74 and a 200-day simple moving average (SMA200) of -$0.22.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 24.55% gain in the last 1 month and extending the period to 3 months gives it a 35.64%, and is 17.78% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 93.25% over the week and 34.47% over the month.
ASLAN Pharmaceuticals Ltd ADR (ASLN) has around 34 employees, a market worth around $11.42M and $11.87M in sales. Profit margin for the company is -380.49%. Distance from 52-week low is 74.74% and -85.39% from its 52-week high. The company has generated returns on investments over the last 12 months (-190.93%).
ASLAN Pharmaceuticals Ltd ADR quarterly earnings per share for the current quarter are estimated at -$0.65.The EPS is expected to grow by 29.08% this year.
ASLAN Pharmaceuticals Ltd ADR (ASLN) Top Institutional Holders
24 institutions hold shares in ASLAN Pharmaceuticals Ltd ADR (ASLN), with institutional investors hold 14.90% of the company’s shares. The shares outstanding are 16.67M, and float is at 16.09M with Short Float at 0.12%. Institutions hold 14.90% of the Float.
The top institutional shareholder in the company is Vivo Capital, LLC with over 2.84 million shares valued at $10.37 million. The investor’s holdings represent 37.39% of the ASLN Shares outstanding. As of Jun 29, 2023, the second largest holder is Tang Capital Management, LLC with 1.13 million shares valued at $4.12 million to account for 14.85% of the shares outstanding. The other top investors are BVF Inc. which holds 1.05 million shares representing 13.82% and valued at over $3.83 million, while Parkman Healthcare Partners LLC holds 6.67% of the shares totaling 0.51 million with a market value of $1.85 million.
